Marvel Biosciences (TSXV:MRVL) Pre-Tax Income : C$-0.82 Mil (TTM As of Oct. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Marvel Biosciences's pretax income for the three months ended in Oct. 2024 was C$-0.28 Mil. Its pretax income for the trailing twelve months (TTM) ended in Oct. 2024 was C$-0.82 Mil. Marvel Biosciences's pretax margin was %.

Marvel Biosciences Pre-Tax Income Historical Data

The historical data trend for Marvel Biosciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Pre-Tax Income Chart

Marvel Biosciences Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Pre-Tax Income

-0.96

-3.04

-2.55

-2.29

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Pre-Tax Income	Get a 7-Day Free Trial													-0.52	-0.23	-0.31	-	-0.28

Competitive Comparison of Marvel Biosciences's Pre-Tax Income

For the Biotechnology subindustry, Marvel Biosciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marvel Biosciences's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's Pre-Tax Income falls into.

Marvel Biosciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Marvel Biosciences's Pretax Income for the fiscal year that ended in Jul. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0	+	0	+	-0.114	+	0	+	0.114
	=	0.00

Marvel Biosciences's Pretax Income for the quarter that ended in Oct. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.232	+	-0.01	+	-0.036	+	0	+	0
	=	-0.28

Pre-Tax Income for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.82 Mil.

Marvel Biosciences (TSXV:MRVL) Pre-Tax Income Explanation

Marvel Biosciences's Pretax Margin for the quarter that ended in Oct. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.278	/	0
	=	%

Marvel Biosciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

MBCOF:USA

Address

505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2

Website

https://www.marvelbiotechnology.com

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Executives